Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Lifestyle Natural Medicines

Navco Readies Launch of Antimicrobial Line

Next Generation Antimicrobial Line Readies for Commercial Launch Vancouver, British Columbia--(Newsfile Corp. - June 5, 2024) - Navco Pharmaceuticals Inc. ( TSXV: NAV ) (" Navco " or the " Company "), is now positioning itself to launch and commer

By: InvestorsObserver

Jun 20 2024
4
295 Views

News HomeNext Generation Antimicrobial Line Readies for Commercial Launch
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2024) - Navco Pharmaceuticals Inc. (TSXV: NAV) ("Navco" or the "Compa… [+3906 chars]

Related

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

The Peanut Allergy Vaccine

Biotech Alert: Searches spiking for these stocks today

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day

Biopharmaceutical Processing Equipment and Consumables Research Report 2024-2031: Lucrative Opportunities in Emerging Economies, Shift Toward Bioprocessing 4.0, & Adoption of Personalized Medicines

Amazy contains hidden drug ingredients

Using AI to repurpose existing drugs for treatment of rare diseases

Study: Companies In States Legal For Medical Cannabis Could Save Thousands In Health Premiums

Researchers harness AI to repurpose existing drugs for treatment of rare diseases

Sermon 51: Mike Adams discusses the many benefits of the sacred resin known as FRANKINCENSE

Combination treatment improves response to immunotherapy for lung cancer

Hemp in Sports: Enhancing Athletic Recovery and Performance Through Natural Products

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee